Percheron Therapeutics LimitedASX: PER

Phase IIb study of ATL1102 in DMD completes recruitment

May 29, 2024 at 3:22 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment